The role of phospholipid methylation in 1-methyl-4-phenyl-pyridinium ion (MPP+)-induced neurotoxicity in PC12 cells

NeuroToxicology

Volumn 26, Issue 6, 2005, Pages 945-957

  Lee, Eun Sook Y ^a   Chen, Hongtao ^a   Charlton, Clivel G ^b   Soliman, Karam F A ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Lysophosphatidylcholine; MPP+; Parkinson's disease; PC12 cells; Phospholipid methylation; S Adenosylmethionine

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; DOPAMINE; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLETHANOLAMINE METHYLTRANSFERASE; PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

ANIMAL CELL; ARTICLE; BRAIN MITOCHONDRION; CELL CULTURE; CELL PROTECTION; CELL STRAIN; CELL VIABILITY; CULTURE MEDIUM; CYTOTOXICITY; DOPAMINE RELEASE; INCUBATION TIME; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NEUROTOXICITY; NONHUMAN; PHOSPHOLIPID METHYLATION; PRIORITY JOURNAL; RAT; TOXICITY TESTING;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; DOPAMINE; LYSOPHOSPHATIDYLCHOLINES; METHYLATION; MPTP POISONING; PC12 CELLS; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPIDS; RATS; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE;

ANIMALIA;

EID: 27944506486     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2005.04.005     Document Type: Article

References (65)

1. S. Abu-Raya, E. Bloch-Shilderman, P.I. Lelkes, V. Trembovler, E. Shohami, and Y. Gutman Characterization of pardaxin-induced dopamine release from pheochromocytoma cells: role of calcium and eicosanoids J Pharmacol Exp Ther 288 1999 399 406
2. K. Aoyama, K. Matsubara, M. Kondo, Y. Murakawa, M. Suno, and K. Yamashita Nicotinamide-N-methyltransferase is higher in the lumbar cerebrospinal fluid of patients with Parkinson's disease Neurosci Lett 298 2001 78 80
3. K. Aoyama, K. Matsubara, K. Okada, S. Fukushima, K. Shimizu, and S. Yamaguchi N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test J Neural Transm 107 2000 985 995
4. S.P. Bagchi Striatal and urinary DOPAC/DA ratio indicate a long-lasting DA release enhancement by MPP+ and MPTP Neurochem Res 23 1998 127 134
5. D. Blum, S. Torch, N. Lambeng, M. Nissou, A.L. Benabid, and R. Sadoul Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog Neurobiol 65 2001 135 172
6. N. Castagnoli Jr., K. Chiba, and A.J. Trevor Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Life Sci 36 1985 225 230
7. C.G. Charlton A parallel relationship between Parkinson's disease and an excess of S-adenosylmethionine-dependent biological methylation in the brain T. Nagatsu Basic Clinical and Therapeutic Aspects of Alzheimer's and Parkinson's Disease vol. 1 1990 Plenum New York 333 339
8. C.G. Charlton, and J. Mack Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain Mol Neurobiol 9 1994 149 161
9. C.G. Charlton, and E.L. Way Tremor induced by S-adenosyl-l-methionine: possible relation to l-dopa effects J Pharm Pharmacol 30 1978 819 820
10. T.S. Chen, E. Koutsilieri, and W.D. Rausch MPP+ selectively affects calcium homeostasis in mesencephalic cell cultures from embryonal C57/Bl6 mice J Neural Transm Gen Sect 100 1995 153 163
11. C.C. Chiueh, S.P. Markey, R.S. Burns, J.N. Johannessen, A. Pert, and I.J. Kopin Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat Eur J Pharmacol 100 1984 189 194
12. P.B. Clarke, and M. Reuben Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter Br J Pharmacol 114 1995 315 322
13. M.W. Cleeter, J.M. Cooper, and A.H. Schapira Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement J Neurochem 58 1992 786 789
14. S.M. Colles, and G.M. Chisolm Lysophosphatidylcholine-induced cellular injury in cultured fibroblasts involves oxidative events J Lipid Res 41 2000 1188 1198
15. F.T. Crews, F. Hirata, and J. Axelrod Identification and properties of methyltransferases that synthesize phosphatidylcholine in rat brain synaptosomes J Neurochem 34 1980 1491 1498
16. B.G. Crowell, R. Benson, D. Shockley, and C.G. Charlton S-Adenosyl-l-methionine decreases motor activity in the rat: similarity to Parkinson's disease-like symptoms Behav Neural Biol 59 1993 186 193
17. W. Fu, H. Luo, S. Parthasarathy, and M.P. Mattson Catecholamines potentiate amyloid beta-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis Neurobiol Dis 5 1998 229 243
18. D.A. Gearhart, E.J. Neafsey, and M.A. Collins Characterization of brain b-carboline-2-N-methyltransferase, an enzyme that may play a role in idiopathic Parkinson's disease Neurochem Res 22 1997 113 121
19. A. Giovanni, B.A. Sieber, R.E. Heikkila, and P.K. Sonsalla Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Part 1: Systemic administration J Pharmacol Exp Ther 270 1994 1000 1007
20. A. Giovanni, P.K. Somali, and R.E. Heikkila Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Part 2: Central administration of 1-methyl-4- phenylpyridinium J Pharmacol Exp Ther 270 1994 1008 1014
21. R.A. Gonzalez-Polo, G. Soler, A. Alvarez, I. Fabregat, and J.M. Fuentes Vitamin E blocks early events induced by 1-methyl-4-phenylpyridinium (MPP+) in cerebellar granule cells J Neurochem 84 2003 305 315
22. F. Hirata, and J. Axelrod Enzymatic methylation of phosphatidylethanolamine increases erythrocyte membrane fluidity Nature 275 1978 219 220
23. J.N. Johannessen, C.C. Chiueh, R.S. Burns, and S.P. Markey Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects Life Sci 36 1985 219 224
24. J.H. Kabarowski, Y. Xu, and O.N. Witte Lysophosphatidylcholine as a ligand for immunoregulation Biochem Pharmacol 64 2002 161 167
25. M. Kalous, H. Rauchova, and Z. Drahota The effect of lysophosphatidylcholine on the activity of various mitochondrial enzymes Biochim Biophys Acta 1098 1992 167 171
26. Y. Kitamura, T. Kosaka, J.I. Kakimura, Y. Matsuoka, Y. Kohno, and Y. Nomura Protective effects of the anti-parkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells Mol Pharmacol 54 1998 1046 1054
27. P. Klivenyi, M.F. Beal, R.J. Ferrante, O.A. Andreassen, M. Wermer, and M.R. Chi Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity J Neurochem 7 1998 2634 2637
28. R.C. Kukreja, H.A. Kontos, M.L. Hess, and E.F. Ellis PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH Circ Res 59 1986 612 619
29. I. Kurkowska-Jastrzebska, A. Wronska, M. Kohutnicka, A. Czlonkowski, and A. Czlonkowska The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine intoxication in mouse Exp Neurol 156 1999 50 61
30. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980
31. +) increases S-adenosyl-l-methionine dependent phospholipid methylation Pharmacol Biochem Behav 70 2001 105 114
32. E.Y. Lee, H. Chen, K.R. Shepherd, N.S. Lamango, K.F.A. Soliman, and C.G. Charlton The inhibitory role of methylation on the binding characteristics of dopamine receptors and transporter Neurosci Res 48 2004 335 344
33. E.Y. Lee, K.F.A. Soliman, and C.G. Charlton Lysophosphatidylcholine decreases locomotor activities and dopamine turnover rate in rats Neurotoxicology 26 2005 27 38
34. J.J. Lee, Y.M. Kim, S.Y. Yin, H.D. Park, M.H. Kang, and J.T. Hong Aggravation of l-DOPA-induced neurotoxicity by tetrahydropapaveroline in PC12 cells Biochem Pharmacol 66 2003 1787 1795
35. J. Lotharius, and K.L. O'Malley The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity J Biol Chem 275 2000 38581 38588
36. J. Maksem, N. Jacobson, and D.H. Neiderhiser Lysophosphatidylcholine- induced gastric injury and ulceration in the guinea pig Am J Pathol 115 1984 288 295
37. G.P. Martin, L.M. el-Hariri, and C. Marriott Bile salt- and lysophosphatidylcholine-induced membrane damage in human erythrocytes J Pharm Pharmacol 44 1992 646 650
38. A. Masamune, Y. Sakai, A. Satoh, M. Fujita, M. Yoshida, and T. Shimosegawa Lysophosphatidylcholine induces apoptosis in AR42J cells Pancreas 22 2001 75 83
39. K. Matsubara, K. Aoyama, M. Suno, and T. Awaya N-methylation underlying Parkinson's disease Neurotoxicol Teratol 24 2002 593 598
40. M. Naoi, S. Matsuura, T. Takahashi, and T. Nagatsu A N-methyltransferase in human brain catalyzes N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin N-methylisoquinolinium ion Biochem Biophys Res Commun 161 1989 1213 1219
41. M. Naoi, W. Maruyama, T. Niwa, and T. Nagatsu Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin J Neural Transm 41 1994 197 205
42. T. Obata, Y. Yamanaka, H. Kinemuchi, and L. Oreland Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP(+)) into the striatum is associated with hydroxyl free radical generation Brain Res 906 2001 170 175
43. K. Oishi, R.L. Raynor, P.A. Charp, and J.F. Kuo Regulation of protein kinase C by lysophospholipids. Potential role in signal transduction J Biol Chem 263 1988 6865 6871
44. C.M. Palmeira, A.J. Moreno, V.M. Madeira, and K.B. Wallace Continuous monitoring of mitochondrial membrane potential in hepatocyte cell suspensions J Pharmacol Toxicol Methods 35 1996 35 43
45. R.B. Parsons, S.W. Smith, R.H. Waring, A.C. Williams, and D.B. Ramsden High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson's disease Neurosci Lett 342 2003 13 16
46. S. Przedborski, and V. Jackson-Lewis Mechanisms of MPTP toxicity Mov Disord 13 1998 35 38
47. R.A. Rabini, R. Galassi, P. Fumelli, N. Dousset, M.L. Solera, and P. Valdiguie Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients Diabetes 43 1994 915 919
48. H. Rollema, M. Skolnik, J. D'Engelbronner, K. Igarashi, E. Usuki, and N. Castagnoli Jr. MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies J Pharmacol Exp Ther 268 1994 380 387
49. + analogues and related charged species J Med Chem 33 1990 2221 2230
50. Z.L. Rossetti, A. Sotgiu, D.E. Sharp, M. Hadjiconstantinou, and N.H. Neff 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro Biochem Pharmacol 37 1988 4573 4574
51. H. Sawada, S. Shimohama, Y. Tamura, T. Kawamura, A. Akaike, and J. Kimura Methyl phenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon J Neurosci Res 43 1996 55 62
52. L. Sedal, K.H. Jennings, G. Allt, M.N. Ghabriel, and M.J. Harrison Influence of fatty acid content of lysophosphatidyl choline on its myelinotoxic properties Eur Neurol 32 1992 4 10
53. G. Selby Parkinson's disease P.J. Vinken Handbook of clinical neurology, disease of the basal ganglia 1975 173 211
54. S.G. Speciale MPTP: Insights into parkinsonian neurodegeneration Neurotoxicol Teratol 24 2002 607 620
55. E. Storey, B.T. Hyman, B. Jenkins, E. Brouillet, J.M. Miller, and B.R. Rosen 1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism J Neurochem 58 1992 1975 1978
56. C.M. Tanner, and J.W. Langston Do environmental toxins cause Parkinson's disease? A critical review Neurology 40 1990 17 30
57. M. Tariq, H.A. Khan, K. Al Moutaery, and S. Al Deeb Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents Brain Res Bull 54 2001 77 82
58. F. Thiès, M.C. Delachambre, M. Bentejac, M. Lagarde, and J. Lecerf Unsaturated fatty acids esterified in 2-acyl-l-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form J Neurochem 59 1992 1110 1116
59. K.F. Tipton, and T.P. Singer Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds J Neurochem 61 1993 1191 1206
60. S.G. Waxman, J.D. Kocsis, and K.C. Nitta Lysophosphatidyl choline-induced focal demyelination in the rabbit corpus callosum J Neurol Sci 44 1979 45 53
61. M. Wender, Z. Adamczewska-Goncerzewicz, J. Dorszewska, J. Szczech, A. Godlewski, and J. Pankrac Myelin lipids in ischemic stroke Neuropathol Pol 29 1991 87 94
62. A.C. Williams, H.S. Pall, G.B. Steventon, S. Green, S. Buttrum, and H. Molloy N-methylation of pyridines and Parkinson's disease Adv Neurol 60 1993 194 196
63. A. Woodgate, G. MacGibbon, M. Walton, and M. Dragunow The toxicity of 6-hydroxydopamine on PC12 and P19 cells Brain Res Mol Brain Res 69 1999 84 92
64. A.M. Wright, J. Bempong, M.L. Kirby, R.L. Barlow, and J.R. Bloomquist Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia. Brain Res 788 1998 215 222
65. N. Yoshinaga, T. Murayama, and Y. Nomura Apoptosis induction by a dopaminergic neurotoxin, 1-methyl-4-phenylpyridinium ion (MPP (+)), and inhibition by epidermal growth factor in GH3 cells Biochem Pharmacol 60 2000 111 120